Boehringer Ingelheim’s Hernexeos receives US FDA accelerated approval for previously treated patients with HER2-mutant advanced NSCLC

Join Pharma | Login

	Editorial


	THE UNACCEPTABLE DELAY
	Wednesday, August 6, 2025
	In a formal communication to Union Minister of State for Health and Family Welfare Anupriya Patel, the All-India Organisation of Chemists and Druggists (AIOCD) has recently expressed deep concern over the
	Past Editorial...

TODAY'S NEWS


10:00 [IST]	Boehringer Ingelheim’s Hernexeos receives US FDA accelerated approval for previously treated patients with HER2-mutant advanced NSCLC
09:00 [IST]	AUTOMA+ 2025 to take place in Vösendorf, Austria from November 24-25

more news >>

TOP NEWS


08:00 [IST]	No further extension of deadline for online submission of WHO-GMP COPP applications: DCGI
08:00 [IST]	Pharma & CROs turn to hybrid cloud infrastructure to safeguard sensitive patient information
08:00 [IST]	Ayush and herbal products exports report growth of 0.6% in Q1 FY26
08:00 [IST]	Kerala IPA to launch one-year programmes to upskill pharmacy professionals
08:00 [IST]	Urgent need for standardization in dental education and clinical practices: Dr Ashok Dhoble
08:00 [IST]	AIOCD vehemently opposes Karnataka govt's proposal to implement third-party inspections of pharmacies

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Dogwood Therapeutics doses first fifty patients in ongoing Halneuron phase 2b CINP clinical trials
17:00 [IST]	Kedrion Biopharma receives US FDA orphan drug designation for plasma-derived treatment for congenital aceruloplasminemia
16:00 [IST]	ProteinQure gets US FDA and Health Canada regulatory clearances to begin phase I trial of PQ203 in US and Canada
15:00 [IST]	Cosmo Pharma & Takeda renew strategic manufacturing pact for global supply of oral treatment for ulcerative colitis
14:00 [IST]	Professor Susan Hopkins appointed as the new chief executive officer of the UKHSA
17:50 [IST]	Sun Pharma introduces Volini Uparna for pilgrims in Maharashtra

more news >>

INTERVIEW


Telangana State’s pharma future hinges on strategic collaboration between industry, academia & government: KV Rambabu
KV Rambabu, president of Telangana State board of Indian Drug Manufacturers Association

Past Interviews...

	What's New?

Biocon net profit down 95 per cent in Q1FY26 Eris Lifesciences records Q1 FY26 revenue at Rs. 773 crore, up 7.4% YoY Lupin reports 51.5 per cent growth in net profit during Q1FY26 Procter & Gamble Health announces first quarter results with sales up 20% for the quarter ended June 30, 2025 Sun Pharma net profit declines 20 per cent in Q1FY26

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers